Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.38658 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.36574 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.37758 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.38148 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32548 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.40033 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.40157 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.354 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.37761 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37431 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.35863 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35368 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.36326 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.36131 | 15 |